Creative Bioarray's hematopoietic cytokines include granulocyte colony-stimulating factor (G-CSF), erythropoietin (EPO), and thrombopoietin (TPO). You can add our hematopoietic cytokines to mimic the bone marrow environment in the human body and culture bone marrow stem cells in vitro for development in areas such as disease research and stem cell therapy. In addition, you can use our hematopoietic cytokines to study the biological functions of genes to discover new targets in disease diagnosis and treatment.

Our hematopoietic cytokines can be used in the development of therapies for cancer chemotherapy, bone marrow transplantation, anemia, and other diseases.

EPO can be used to treat anemia caused by kidney failure, patients with non-small cell lung cancer, and chemotherapy-induced anemia.
G-CSF can be used to treat anemia in the recovery period after bone marrow transplantation or chemotherapy for leukemia and chemotherapy-induced leukopenia.
Dendritic colony-stimulating factor (GM-CSF) can be used to promote leukocyte production, improve granulocyte and macrophage function, and treat immune reconstitution after bone marrow transplantation.
Derived hepatocyte growth factor (HGF) can be used to enhance the self-renewal and proliferative capacity of hematopoietic stem cells and can be used for pre- and post-hematopoietic stem cell transplantation therapy.
Human cytokine IL-11 can be used for the treatment of leukopenia and thrombocytopenia induced by chemotherapy or radiation therapy, as well as for the treatment of patients with hemophilia.